Skip to main content

Table 1 Comparisons of demographic, clinical characteristics and bacteria alpha diversity between BPH group and normal control group

From: The impact of urine microbiota in patients with lower urinary tract symptoms

  BPH (n = 77) Control (n = 30) P value
Demographic
 Age 69.44 ± 8.23 61.97 ± 8.32  < 0.001a
 Body mass index 24.17 ± 3.33 24.55 ± 2.87 0.616
Clinical Characteristics
 Fasting blood glucose 110.89 ± 17.05 114.48 ± 26.77 0.436
 Prostate specific antigen (PSA) 3.02 ± 3.21 2.37 ± 3.94 0.406
 Free PSA 0.60 ± 0.11 0.69 ± 1.25 0.613
 Hemoglobin A1c (%) 5.81 ± 0.67 5.88 ± 0.53 0.660
 Creatinine 0.98 ± 0.22 0.93 ± 0.18 0.393
 BUN 15.44 ± 4.94 13.22 ± 2.93 0.036
 HDL 53.93 ± 24.43 47.91 ± 11.76 0.239
 Cholesterol 181.51 ± 42.61 182.28 ± 28.15 0.933
 LDL 110.61 ± 33.82 116.75 ± 26.46 0.409
 Testosterone 551.68 ± 246.50 540.75 ± 158.96 0.836
 GOT 25.96 ± 7.63 26.50 ± 7.79 0.804
 GPT 26.133 ± 12.86 30.56 ± 20.82 0.210
 TG 108.68 ± 66.63 102.52 ± 44.11 0.667
 IPSS 6.25 ± 4.19 2.16 ± 1.37  < 0.001a
 Quality of life scores 2.09 ± 0.68 1.2 ± 0.41  < 0.001a
Parameter of Bacterial Alpha Diversity
 Observed species 256.17 ± 65.29 254.70 ± 51.58 0.912
 Chao1 284.40 ± 65.63 288.21 ± 63.05 0.786
 ACE index 277.65 ± 64.78 280.21 ± 57.85 0.850
 Shannon index 5.81 ± 1.04 5.59 ± 0.90 0.314
 Simpson index 0.93 ± 0.08 0.92 ± 0.06 0.697
  1. aIPSS: International Prostate Symptom Score